Consistent survival in consecutive cases of life-supporting porcine kidney xenotransplantation using 10GE source pigs

Abstract Xenotransplantation represents a possible solution to the organ shortage crisis and is an imminent clinical reality with long-term xenograft survival in pig-to-nonhuman primate (NHP) heart and kidney large animal models, and short-term success in recent human decedent and clinical studies....

Full description

Bibliographic Details
Main Authors: Daniel Eisenson, Yu Hisadome, Michelle Santillan, Hayato Iwase, WeiLi Chen, Akira Shimizu, Alex Schulick, Du Gu, Armaan Akbar, Alice Zhou, Kristy Koenig, Kasinath Kuravi, Farzana Rahman, Lori Sorrells, Lars Burdorf, Kristina DeSmet, Daniel Warren, Leigh Peterson, Marc Lorber, David Ayares, Andrew Cameron, Kazuhiko Yamada
Format: Article
Language:English
Published: Nature Portfolio 2024-04-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-024-47679-6
_version_ 1797199371907891200
author Daniel Eisenson
Yu Hisadome
Michelle Santillan
Hayato Iwase
WeiLi Chen
Akira Shimizu
Alex Schulick
Du Gu
Armaan Akbar
Alice Zhou
Kristy Koenig
Kasinath Kuravi
Farzana Rahman
Lori Sorrells
Lars Burdorf
Kristina DeSmet
Daniel Warren
Leigh Peterson
Marc Lorber
David Ayares
Andrew Cameron
Kazuhiko Yamada
author_facet Daniel Eisenson
Yu Hisadome
Michelle Santillan
Hayato Iwase
WeiLi Chen
Akira Shimizu
Alex Schulick
Du Gu
Armaan Akbar
Alice Zhou
Kristy Koenig
Kasinath Kuravi
Farzana Rahman
Lori Sorrells
Lars Burdorf
Kristina DeSmet
Daniel Warren
Leigh Peterson
Marc Lorber
David Ayares
Andrew Cameron
Kazuhiko Yamada
author_sort Daniel Eisenson
collection DOAJ
description Abstract Xenotransplantation represents a possible solution to the organ shortage crisis and is an imminent clinical reality with long-term xenograft survival in pig-to-nonhuman primate (NHP) heart and kidney large animal models, and short-term success in recent human decedent and clinical studies. However, concerns remain about safe clinical translation of these results, given the inconsistency in published survival as well as key differences between preclinical procurement and immunosuppression and clinical standards-of-care. Notably, no studies of solid organ pig-to-NHP transplantation have achieved xenograft survival longer than one month without CD40/CD154 costimulatory blockade, which is not currently an FDA-approved immunosuppression strategy. We now present consistent survival in consecutive cases of pig-to-NHP kidney xenotransplantation, including long-term survival after >3 hours of xenograft cold preservation time as well as long-term survival using FDA-approved immunosuppression. These data provide critical supporting evidence for the safety and feasibility of clinical kidney xenotransplantation. Moreover, long-term survival without CD40/CD154 costimulatory blockade may provide important insights for immunosuppression regimens to be considered for first-in-human clinical trials.
first_indexed 2024-04-24T07:14:42Z
format Article
id doaj.art-fb29612df711444fae0734b22e8d1904
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-04-24T07:14:42Z
publishDate 2024-04-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-fb29612df711444fae0734b22e8d19042024-04-21T11:24:10ZengNature PortfolioNature Communications2041-17232024-04-011511710.1038/s41467-024-47679-6Consistent survival in consecutive cases of life-supporting porcine kidney xenotransplantation using 10GE source pigsDaniel Eisenson0Yu Hisadome1Michelle Santillan2Hayato Iwase3WeiLi Chen4Akira Shimizu5Alex Schulick6Du Gu7Armaan Akbar8Alice Zhou9Kristy Koenig10Kasinath Kuravi11Farzana Rahman12Lori Sorrells13Lars Burdorf14Kristina DeSmet15Daniel Warren16Leigh Peterson17Marc Lorber18David Ayares19Andrew Cameron20Kazuhiko Yamada21Department of Surgery, Division of Transplantation, The Johns Hopkins School of MedicineDepartment of Surgery, Division of Transplantation, The Johns Hopkins School of MedicineDepartment of Surgery, Division of Transplantation, The Johns Hopkins School of MedicineDepartment of Surgery, Division of Transplantation, The Johns Hopkins School of MedicineDepartment of Surgery, Division of Transplantation, The Johns Hopkins School of MedicineDepartment of Pathology, Nippon Medical SchoolDepartment of Surgery, Division of Transplantation, The Johns Hopkins School of MedicineDepartment of Surgery, Division of Transplantation, The Johns Hopkins School of MedicineDepartment of Surgery, Division of Transplantation, The Johns Hopkins School of MedicineDepartment of Surgery, Division of Transplantation, The Johns Hopkins School of MedicineDepartment of Surgery, Division of Transplantation, The Johns Hopkins School of MedicineUnited Therapeutics CorporationUnited Therapeutics CorporationUnited Therapeutics CorporationUnited Therapeutics CorporationUnited Therapeutics CorporationDepartment of Surgery, Division of Transplantation, The Johns Hopkins School of MedicineUnited Therapeutics CorporationUnited Therapeutics CorporationUnited Therapeutics CorporationDepartment of Surgery, Division of Transplantation, The Johns Hopkins School of MedicineDepartment of Surgery, Division of Transplantation, The Johns Hopkins School of MedicineAbstract Xenotransplantation represents a possible solution to the organ shortage crisis and is an imminent clinical reality with long-term xenograft survival in pig-to-nonhuman primate (NHP) heart and kidney large animal models, and short-term success in recent human decedent and clinical studies. However, concerns remain about safe clinical translation of these results, given the inconsistency in published survival as well as key differences between preclinical procurement and immunosuppression and clinical standards-of-care. Notably, no studies of solid organ pig-to-NHP transplantation have achieved xenograft survival longer than one month without CD40/CD154 costimulatory blockade, which is not currently an FDA-approved immunosuppression strategy. We now present consistent survival in consecutive cases of pig-to-NHP kidney xenotransplantation, including long-term survival after >3 hours of xenograft cold preservation time as well as long-term survival using FDA-approved immunosuppression. These data provide critical supporting evidence for the safety and feasibility of clinical kidney xenotransplantation. Moreover, long-term survival without CD40/CD154 costimulatory blockade may provide important insights for immunosuppression regimens to be considered for first-in-human clinical trials.https://doi.org/10.1038/s41467-024-47679-6
spellingShingle Daniel Eisenson
Yu Hisadome
Michelle Santillan
Hayato Iwase
WeiLi Chen
Akira Shimizu
Alex Schulick
Du Gu
Armaan Akbar
Alice Zhou
Kristy Koenig
Kasinath Kuravi
Farzana Rahman
Lori Sorrells
Lars Burdorf
Kristina DeSmet
Daniel Warren
Leigh Peterson
Marc Lorber
David Ayares
Andrew Cameron
Kazuhiko Yamada
Consistent survival in consecutive cases of life-supporting porcine kidney xenotransplantation using 10GE source pigs
Nature Communications
title Consistent survival in consecutive cases of life-supporting porcine kidney xenotransplantation using 10GE source pigs
title_full Consistent survival in consecutive cases of life-supporting porcine kidney xenotransplantation using 10GE source pigs
title_fullStr Consistent survival in consecutive cases of life-supporting porcine kidney xenotransplantation using 10GE source pigs
title_full_unstemmed Consistent survival in consecutive cases of life-supporting porcine kidney xenotransplantation using 10GE source pigs
title_short Consistent survival in consecutive cases of life-supporting porcine kidney xenotransplantation using 10GE source pigs
title_sort consistent survival in consecutive cases of life supporting porcine kidney xenotransplantation using 10ge source pigs
url https://doi.org/10.1038/s41467-024-47679-6
work_keys_str_mv AT danieleisenson consistentsurvivalinconsecutivecasesoflifesupportingporcinekidneyxenotransplantationusing10gesourcepigs
AT yuhisadome consistentsurvivalinconsecutivecasesoflifesupportingporcinekidneyxenotransplantationusing10gesourcepigs
AT michellesantillan consistentsurvivalinconsecutivecasesoflifesupportingporcinekidneyxenotransplantationusing10gesourcepigs
AT hayatoiwase consistentsurvivalinconsecutivecasesoflifesupportingporcinekidneyxenotransplantationusing10gesourcepigs
AT weilichen consistentsurvivalinconsecutivecasesoflifesupportingporcinekidneyxenotransplantationusing10gesourcepigs
AT akirashimizu consistentsurvivalinconsecutivecasesoflifesupportingporcinekidneyxenotransplantationusing10gesourcepigs
AT alexschulick consistentsurvivalinconsecutivecasesoflifesupportingporcinekidneyxenotransplantationusing10gesourcepigs
AT dugu consistentsurvivalinconsecutivecasesoflifesupportingporcinekidneyxenotransplantationusing10gesourcepigs
AT armaanakbar consistentsurvivalinconsecutivecasesoflifesupportingporcinekidneyxenotransplantationusing10gesourcepigs
AT alicezhou consistentsurvivalinconsecutivecasesoflifesupportingporcinekidneyxenotransplantationusing10gesourcepigs
AT kristykoenig consistentsurvivalinconsecutivecasesoflifesupportingporcinekidneyxenotransplantationusing10gesourcepigs
AT kasinathkuravi consistentsurvivalinconsecutivecasesoflifesupportingporcinekidneyxenotransplantationusing10gesourcepigs
AT farzanarahman consistentsurvivalinconsecutivecasesoflifesupportingporcinekidneyxenotransplantationusing10gesourcepigs
AT lorisorrells consistentsurvivalinconsecutivecasesoflifesupportingporcinekidneyxenotransplantationusing10gesourcepigs
AT larsburdorf consistentsurvivalinconsecutivecasesoflifesupportingporcinekidneyxenotransplantationusing10gesourcepigs
AT kristinadesmet consistentsurvivalinconsecutivecasesoflifesupportingporcinekidneyxenotransplantationusing10gesourcepigs
AT danielwarren consistentsurvivalinconsecutivecasesoflifesupportingporcinekidneyxenotransplantationusing10gesourcepigs
AT leighpeterson consistentsurvivalinconsecutivecasesoflifesupportingporcinekidneyxenotransplantationusing10gesourcepigs
AT marclorber consistentsurvivalinconsecutivecasesoflifesupportingporcinekidneyxenotransplantationusing10gesourcepigs
AT davidayares consistentsurvivalinconsecutivecasesoflifesupportingporcinekidneyxenotransplantationusing10gesourcepigs
AT andrewcameron consistentsurvivalinconsecutivecasesoflifesupportingporcinekidneyxenotransplantationusing10gesourcepigs
AT kazuhikoyamada consistentsurvivalinconsecutivecasesoflifesupportingporcinekidneyxenotransplantationusing10gesourcepigs